KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Clover Health Investments (CLOV) EPS (Weighted Average and Diluted) (2019 - 2025)

Clover Health Investments (CLOV) has disclosed EPS (Weighted Average and Diluted) for 7 consecutive years, with -$0.1 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 150.0% year-over-year to -$0.1, compared with a TTM value of -$0.17 through Dec 2025, down 70.0%, and an annual FY2025 reading of -$0.17, down 88.89% over the prior year.
  • EPS (Weighted Average and Diluted) was -$0.1 for Q4 2025 at Clover Health Investments, down from -$0.05 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.01 in Q2 2024 and bottomed at -$0.8 in Q2 2021.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.15, with a median of -$0.1 recorded in 2025.
  • The sharpest move saw EPS (Weighted Average and Diluted) crashed 8100.0% in 2021, then surged 116.67% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.44 in 2021, then surged by 61.36% to -$0.17 in 2022, then increased by 29.41% to -$0.12 in 2023, then skyrocketed by 66.67% to -$0.04 in 2024, then tumbled by 150.0% to -$0.1 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for CLOV at -$0.1 in Q4 2025, -$0.05 in Q3 2025, and -$0.02 in Q2 2025.